全文获取类型
收费全文 | 152577篇 |
免费 | 14266篇 |
国内免费 | 5086篇 |
专业分类
耳鼻咽喉 | 972篇 |
儿科学 | 2404篇 |
妇产科学 | 1749篇 |
基础医学 | 31834篇 |
口腔科学 | 3495篇 |
临床医学 | 10895篇 |
内科学 | 24274篇 |
皮肤病学 | 3102篇 |
神经病学 | 12606篇 |
特种医学 | 3495篇 |
外国民族医学 | 48篇 |
外科学 | 12462篇 |
综合类 | 17381篇 |
现状与发展 | 26篇 |
预防医学 | 6244篇 |
眼科学 | 1434篇 |
药学 | 19362篇 |
37篇 | |
中国医学 | 4644篇 |
肿瘤学 | 15465篇 |
出版年
2024年 | 365篇 |
2023年 | 2435篇 |
2022年 | 5233篇 |
2021年 | 6204篇 |
2020年 | 5238篇 |
2019年 | 5510篇 |
2018年 | 5343篇 |
2017年 | 5321篇 |
2016年 | 5156篇 |
2015年 | 5935篇 |
2014年 | 8615篇 |
2013年 | 9241篇 |
2012年 | 8042篇 |
2011年 | 9906篇 |
2010年 | 8101篇 |
2009年 | 8312篇 |
2008年 | 8145篇 |
2007年 | 7412篇 |
2006年 | 6559篇 |
2005年 | 6055篇 |
2004年 | 5179篇 |
2003年 | 4600篇 |
2002年 | 3781篇 |
2001年 | 3211篇 |
2000年 | 2706篇 |
1999年 | 2475篇 |
1998年 | 2337篇 |
1997年 | 2174篇 |
1996年 | 1986篇 |
1995年 | 1788篇 |
1994年 | 1658篇 |
1993年 | 1485篇 |
1992年 | 1123篇 |
1991年 | 1006篇 |
1990年 | 894篇 |
1989年 | 685篇 |
1988年 | 649篇 |
1987年 | 596篇 |
1986年 | 676篇 |
1985年 | 961篇 |
1984年 | 880篇 |
1983年 | 672篇 |
1982年 | 664篇 |
1981年 | 562篇 |
1980年 | 509篇 |
1979年 | 426篇 |
1978年 | 263篇 |
1977年 | 214篇 |
1976年 | 220篇 |
1975年 | 122篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
目的探讨重睑术中采用经重睑切口的上睑旋转皮瓣矫正轻、中度内眦赘皮的疗效。方法回顾分析 2016 年 7 月—2017 年 10 月,重睑术中采用经重睑切口的上睑旋转皮瓣矫正轻、中度睑板型内眦赘皮合并单睑的 34 例患者(试验组)临床资料;以同期 38 例接受传统“Z”成形内眦开大术联合重睑术患者为对照(对照组)。两组患者年龄及内侧赘皮分度比较,差异无统计学意义(P>0.05)。于术前及术后 6 d、6 个月测量眼裂长度,计算眼裂长度改善程度;参照内眦赘皮矫正标准评价手术疗效。 结果两组患者切口均Ⅰ期愈合,并获随访 6 个月。两组内眦赘皮明显矫正。试验组内眦处无切口;对照组遗留瘢痕,其中 6 例增生明显。术后 6 d 试验组及对照组眼裂长度改善程度分别为 3.63%±0.07%、3.70%±0.05%;术后 6 个月分别为 4.64%±0.09%、4.46%±0.10%;两组比较差异均无统计学意义(t=0.005,P=0.996;t=0.287,P=0.871)。术后 6 个月疗效评价,试验组优 20 例、良 12 例、差 2 例,优良率 94.12%;对照组优 16 例、良 16 例、差 6 例,优良率 84.21%;差异无统计学意义(χ2=0.796,P=0.372)。 结论经重睑切口的上睑旋转皮瓣矫正轻、中度内眦赘皮手术操作简便、效果满意,内眦处无瘢痕形成。 相似文献
42.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
43.
44.
《Vaccine》2015,33(43):5861-5867
River blindness, caused by the filarial parasite Onchocerca volvulus, is a major socio-economic and public health problem in Sub-Saharan Africa. In January 2015, The Onchocerciasis Vaccine for Africa (TOVA) Initiative has been launched with the aim of providing new tools to complement mass drug administration (MDA) of ivermectin, thereby promoting elimination of onchocerciasis in Africa. In this context we here present Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (Ov-GAPDH) as a possible DNA vaccine candidate. We report that in a laboratory model for filariasis, immunization with Ov-GAPDH led to a significant reduction of adult worm load and microfilaraemia in BALB/c mice after challenge infection with the filarial parasite Litomosoides sigmodontis. Mice were either vaccinated with Ov-GAPDH.DNA plasmid (Ov-pGAPDH.DNA) alone or in combination with recombinantly expressed Ov-GAPDH protein (Ov-rGAPDH). During the following challenge infection of immunized and control mice with L. sigmodontis, those formulations which included the DNA plasmid, led to a significant reduction of adult worm loads (up to 57% median reduction) and microfilaraemia (up to 94% reduction) in immunized animals. In a further experiment, immunization with a mixture of four overlapping, synthetic Ov-GAPDH peptides (Ov-GAPDHpept), with alum as adjuvant, did not significantly reduce worm loads. Our results indicate that DNA vaccination with Ov-GAPDH has protective potential against filarial challenge infection in the mouse model. This suggests a transfer of the approach into the cattle Onchocerca ochengi model, where it is possible to investigate the effects of this vaccination in the context of a natural host–parasite relationship. 相似文献
45.
《Journal of Clinical Orthopaedics and Trauma》2019,10(2):380-386
Additive manufacturing is a rapidly emerging technology which is being successfully implemented in the various field of medicine as well as in orthopaedics, where it has applications in reducing cartilage defects and treatments of bones. The technology helps through systematic collection of information about the shape of the "defects" and precise fabrication of complex 3D constructs such as cartilage, heart valve, trachea, myocardial bone tissue and blood vessels. In this paper, a large number of the relevant research papers on the additive manufacturing and its application in medical specifically orthopaedics are identified through Scopus had been studied using Bibliometric analysis and application analysis is undertaken. The bibliometric analysis shows that there is an increasing trend in the research reports on additive manufacturing applications in the field of orthopaedics. Discussions are on using technological advancement like scanning techniques and various challenges of the orthopaedic being met by additive manufacturing technology. For patient-specific orthopaedic applications, these techniques incorporate clinical practice and use for effective planning. 3D printed models printed by this technology are accepted for orthopaedic surgery such as revision of lumbar discectomy, pelvic surgery and large scapular osteochondroma. The applications of additive manufacturing in orthopaedics will experience a rapid translation in future. An orthopaedic surgeon can convert need/idea into a reality by using computer-aided design (CAD) software, analysis software to facilitate the manufacturing. Thus, AM provides a comprehensive opportunity to manufacture orthopaedic implantable medical devices. 相似文献
46.
Consensus on the use and monitoring of anti‐TNF‐α therapies for rheumatic diseases in Hong Kong 2005
《International journal of rheumatic diseases》2006,9(2):175-180
The development and use of the tumour necrosis factor (TNF) antagonists is a major breakthrough in the treatment of many rheumatic diseases. Although these novel agents are undoubtedly superior to conventional therapeutic modalities, their costs and potential adverse effects are of concern. The current consensus statements were developed in early 2005 to help practicing rheumatologists identify which adult patients may benefit from anti‐TNF therapies and highlight their potential toxicities. The Hong Kong Society of Rheumatology has developed a registry on the use of the biologics in our local patients with chronic rheumatic disorders. Because the indications and novel data regarding the TNF inhibitors are ever changing, this consensus will be updated regularly. 相似文献
47.
A method is presented for 3D MRI in an extended field of view (FOV) based on continuous motion of the patient table and an efficient acquisition scheme. A gradient-echo MR pulse sequence is applied with lateral (left-right (L/R)) frequency-encoding direction and slab selection along the direction of motion. Compensation for the table motion is achieved by a combination of slab tracking and data alignment in hybrid space. The method allows fast k-space coverage to be achieved, especially when a short sampling FOV is chosen along the direction of table motion, as is desirable for good image quality. The method can be incorporated into different acquisitions schemes, including segmented k-space scanning, which allows for contrast variation with the use of magnetization preparation. Head-to-toe images of volunteers were obtained with good quality using 3D spoiled gradient-echo sequences. As an example of magnetization-prepared imaging, fat/water separated images were acquired using chemical shift selective (CHESS) presaturation pulses. 相似文献
48.
皮质发育障碍模型的建立及其致痫敏感性的研究 总被引:1,自引:0,他引:1
目的:建立皮质发育障碍模型,探讨皮质发育障碍模型的敏感性。方法:在SD大鼠孕17d腹腔注入1,3-二氯乙烯-亚硝基脲(BCNU)制作皮质发育障碍模型;Nissl染色观察P60d仔鼠病理变化;选取P60d雄性仔鼠,腹腔注射氯化锂-毛果芸香碱,分别比较两组大鼠癫发生的潜伏期、持续状态时间和死亡率。结果:同龄仔鼠脑组织湿重实验组比对照组显著减轻(P<0.01);Nissl染色显示皮质变薄、皮质层次紊乱、海马区域异位细胞异常聚集;有皮质发育障碍的仔鼠注射氯化锂-毛果芸香碱后,癫发生的潜伏期显著缩短(P<0.01),癫持续状态时间延长(P<0.01),死亡率显著升高(P<0.05)。结论:BCNU致皮质发育障碍模型具有癫易感性。 相似文献
49.
Andreas Karatsaidis Olav Schreurs Kristen Helgeland Tony Axéll Karl Schenck 《Journal of oral pathology & medicine》2003,32(5):275-281
BACKGROUND: Common clinical forms of oral lichen planus (OLP) and oral lichenoid reactions (OLR) are erythematous (ERY) or reticular (RET). The purpose of this study was to find histopathological changes that differ between these forms. METHODS: Epithelial thickness, epithelial proliferation rate, apoptosis, and HLA-DR expression were compared among 10 reticular and 12 erythematous lesions, and 11 normal oral mucosa samples (NOM). RESULTS: The epithelium in ERY was thinner than in NOM, whereas RET showed values between ERY and NOM. Cell proliferation increased significantly in ERY as compared with RET and NOM, with no difference between RET and NOM. Relative numbers of epithelial cell nuclei displaying visible chromatin condensation were reduced in ERY form. CONCLUSIONS: The markedly increased cell proliferation in ERY supports the notion that this form displays a higher disease activity as compared to RET. It can therefore be important to study each disease form separately. 相似文献
50.
Marcondes C Fran?a Maria E Calcagnotto Jaderson C da Costa Iscia Lopes-Cendes 《Movement disorders》2006,21(7):1051-1053
Spinocerebellar ataxia (SCA) types 2 and 3 are autosomal-dominant neurodegenerative disorders caused by mutations in two different genes. We identified mutations for SCA2 and SCA3 segregating simultaneously in a single Brazilian family. The index patient had SCA2, whereas her two second-degree cousins had SCA3. Disease was more rapidly progressive in the SCA2 patient, who presented severe brainstem and pancerebellar atrophy, as opposed to the two SCA3 patients, who had only mild cerebellar vermian atrophy. In such situations, molecular confirmation of all patients may avoid misdiagnosis of SCA subtypes and eventual errors in predictive testing of unaffected family members. 相似文献